AVD-104

· Aviceda Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVD-104, covering 2025-07-14 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]

See pricing